Seyed Ebrahim Alavi

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Venues

Pharmaceutics

Bioconjugate chemistry

International journal of molecular sciences

Journal of drug targeting

University of Queensland

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland Jul 1o 2018

Australia

Tutor :: School of Pharmacy

Education History

University of Queensland Oct 11o 2016

Australia

PHD :: School of Pharmacy

Publications

Xuping Jin, Seyed Ebrahim Alavi, Abbas Shafiee, Vania Rodrigues Leite-Silva, Kiarash Khosrotehrani, Yousuf H Mohammed
Metamorphosis of Topical Semisolid Products-Understanding the Role of Rheological Properties in Drug Permeation under the "in Use" Condition. Pharmaceutics 15 (6) (2023)
Seyed Ebrahim Alavi, Max Gholami, Hasan Ebrahimi Shahmabadi, Peter Reher
Resorbable GBR Scaffolds in Oral and Maxillofacial Tissue Engineering: Design, Fabrication, and Applications. Journal of clinical medicine 12 (22) (2023)
Xuping Jin, Seyed Ebrahim Alavi, Abbas Shafiee, Vania Rodrigues Leite-Silva, Kiarash Khosrotehrani, Yousuf H Mohammed
Metamorphosis of Topical Semisolid Products-Understanding the Role of Rheological Properties in Drug Permeation under the "in Use" Condition. Pharmaceutics 15 (6) (2023)
Khadeejeh Al-Smadi, Masood Ali, Seyed Ebrahim Alavi, Xuping Jin, Mohammad Imran, Vania R Leite-Silva, Yousuf H Mohammed
Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review. Cells 12 (19) (2023)
Seyed Ebrahim Alavi, Aun Raza, Max Gholami, Michael Giles, Rayan Al-Sammak, Ali Ibrahim, Hasan Ebrahimi Shahmabadi, Lavanya A Sharma
Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens. Pharmaceutics 14 (11) (2022)
Mohsen Ghaferi, Aun Raza, Maedeh Koohi, Warda Zahra, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics 14 (10) (2022)
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 14 (4) (2022)
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy. Pharmaceutics 14 (8) (2022)
Seyed Ebrahim Alavi, Urooj Bakht, Maedeh Koohi Moftakhari Esfahani, Hossein Adelnia, Seyed Hossein Abdollahi, Hasan Ebrahimi Shahmabadi, Aun Raza
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics. Pharmaceutics 14 (8) (2022)
Seyed Ebrahim Alavi, Peter J Cabot, Aun Raza, Peter Michael Moyle
Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne-Azide Cycloaddition and Evaluation of Their Biological Activity. Bioconjugate chemistry 32 (4) (2021)
Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J Cabot, Nazrul Islam, Emad L Izake
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells. Pharmaceutics 13 (10) (2021)
Seyed Ebrahim Alavi, Peter John Cabot, Gee Yi Yap, Peter Michael Moyle
Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne-Azide Cycloaddition. Bioconjugate chemistry 31 (7) (2020)
Mohsen Ghaferi, Mohammad Javad Asadollahzadeh, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation. International journal of molecular sciences 21 (2) (2020)
Mohsen Ghaferi, Maedeh Koohi Moftakhari Esfahani, Aun Raza, Sitah Alharthi, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. Journal of drug targeting 29 (2) (2020)
Sitah Alharthi, Seyed Ebrahim Alavi, Mahasen Ali Radwan, Mona Mohamed El Khatib, Ibrahim Abdullah AlSarra
Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease. Scientific reports 9 (1) (2019)
Seyed Ebrahim Alavi, Peter J Cabot, Peter Michael Moyle
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency. Molecular pharmaceutics 16 (6) (2019)
Seyed Ebrahim Alavi, Sitah Muflih Al Harthi, Hasan Ebrahimi Shahmabadi, Azim Akbarzadeh
Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent. International journal of molecular sciences 20 (7) (2019)

Seyed Ebrahim Alavi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Seyed Ebrahim Alavi